慢性乙型肝炎-话题@MedSci

#慢性乙型肝炎#

119篇内容 | 4222人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1271274, encodeId=a0b412e12744a, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=J Viral Hepat：抗病毒治疗后获得病毒抑制的慢性乙型肝炎患者与非活性期慢性乙型肝炎患者间整体存活率的比较, objectType=article, longId=137872, objectId=094213e872ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=094213e872ba, replyNumber=0, likeNumber=73, createdTime=2018-05-12, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=094213e872ba, moduleTitle=J Viral Hepat：抗病毒治疗后获得病毒抑制的慢性乙型肝炎患者与非活性期慢性乙型肝炎患者间整体存活率的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=094213e872ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271273, encodeId=fd9b12e12737d, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=《2018年亚裔美国人群慢性乙型肝炎管理专家共识》摘译, objectType=article, longId=137721, objectId=0dee13e721b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0dee13e721b1, replyNumber=0, likeNumber=29, createdTime=2018-05-11, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0dee13e721b1, moduleTitle=《2018年亚裔美国人群慢性乙型肝炎管理专家共识》摘译, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0dee13e721b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271272, encodeId=85f412e1272c0, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=Liver Int：在慢性乙型肝炎患者中，FibroStage是诊断显著纤维化、晚期纤维化和肝硬化的较好模型, objectType=article, longId=135700, objectId=2777135e00dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2777135e00dc, replyNumber=0, likeNumber=68, createdTime=2018-04-19, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2777135e00dc, moduleTitle=Liver Int：在慢性乙型肝炎患者中，FibroStage是诊断显著纤维化、晚期纤维化和肝硬化的较好模型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2777135e00dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271271, encodeId=596712e1271d9, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=《2018年美国肝病学会乙型肝炎指导：慢性乙型肝炎预防、诊断和治疗（更新）》摘译, objectType=article, longId=135047, objectId=895713504e37, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=895713504e37, replyNumber=0, likeNumber=31, createdTime=2018-04-13, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=895713504e37, moduleTitle=《2018年美国肝病学会乙型肝炎指导：慢性乙型肝炎预防、诊断和治疗（更新）》摘译, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=895713504e37)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271270, encodeId=920112e12704c, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=Clin Transl Gastroenterol：慢性乙型肝炎患者并发症增加, objectType=article, longId=133569, objectId=65a013356935, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65a013356935, replyNumber=0, likeNumber=61, createdTime=2018-03-28, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65a013356935, moduleTitle=Clin Transl Gastroenterol：慢性乙型肝炎患者并发症增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65a013356935)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271269, encodeId=95cb12e126955, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=Hepatol Res：基线维生素D水平与慢性乙型肝炎患者遗传决定因素和病毒学应答的相关性, objectType=article, longId=132814, objectId=ceeb13281407, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ceeb13281407, replyNumber=0, likeNumber=78, createdTime=2018-03-20, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ceeb13281407, moduleTitle=Hepatol Res：基线维生素D水平与慢性乙型肝炎患者遗传决定因素和病毒学应答的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ceeb13281407)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271268, encodeId=895712e1268cf, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=2018 AASLD指南：慢性乙型肝炎的预防，诊断和治疗（更新版）, objectType=article, longId=132238, objectId=9f1d132238f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f1d132238f5, replyNumber=0, likeNumber=28, createdTime=2018-03-14, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f1d132238f5, moduleTitle=2018 AASLD指南：慢性乙型肝炎的预防，诊断和治疗（更新版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f1d132238f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271267, encodeId=fd0712e1267df, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=Adv Clin Exp Med：乙型肝炎病毒逆转录酶的突变与慢性乙型肝炎患者的肝病严重程度相关, objectType=article, longId=129625, objectId=c6b31296257e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6b31296257e, replyNumber=0, likeNumber=75, createdTime=2018-02-12, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6b31296257e, moduleTitle=Adv Clin Exp Med：乙型肝炎病毒逆转录酶的突变与慢性乙型肝炎患者的肝病严重程度相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6b31296257e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271266, encodeId=919412e126606, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=Dig Liver Dis：一新型的非侵入性指标，用于预测慢性乙型肝炎患者中度至重度纤维化, objectType=article, longId=129241, objectId=16c512924197, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16c512924197, replyNumber=0, likeNumber=57, createdTime=2018-02-09, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16c512924197, moduleTitle=Dig Liver Dis：一新型的非侵入性指标，用于预测慢性乙型肝炎患者中度至重度纤维化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16c512924197)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271265, encodeId=742012e126593, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=Liver Int：慢性乙型肝炎患者血清丙氨酸氨基转移酶水平及肝脏疾病相关死亡率的关系, objectType=article, longId=128578, objectId=fd1d1285e8c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd1d1285e8c8, replyNumber=0, likeNumber=85, createdTime=2018-02-03, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd1d1285e8c8, moduleTitle=Liver Int：慢性乙型肝炎患者血清丙氨酸氨基转移酶水平及肝脏疾病相关死亡率的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd1d1285e8c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271264, encodeId=1e4012e126408, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=Gastroenterology：TLR7兴奋剂—GS-9620，增加了慢性乙型肝炎患者HBV特异性T细胞和自然杀伤细胞的反应, objectType=article, longId=128450, objectId=3188128450b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3188128450b5, replyNumber=0, likeNumber=30, createdTime=2018-02-02, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3188128450b5, moduleTitle=Gastroenterology：TLR7兴奋剂—GS-9620，增加了慢性乙型肝炎患者HBV特异性T细胞和自然杀伤细胞的反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3188128450b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271263, encodeId=37c412e12630c, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=二维剪切波弹性成像评估慢性乙型肝炎肝纤维化临床应用指南, objectType=article, longId=125901, objectId=94fb1259016e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94fb1259016e, replyNumber=0, likeNumber=32, createdTime=2018-01-09, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94fb1259016e, moduleTitle=二维剪切波弹性成像评估慢性乙型肝炎肝纤维化临床应用指南, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=94fb1259016e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271262, encodeId=41d212e12623f, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=J Gastroenterol Hepatol：慢性乙型肝炎感染的自然史中，存在三种类型的起始密码子变异, objectType=article, longId=123522, objectId=2d6612352220, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d6612352220, replyNumber=0, likeNumber=63, createdTime=2017-12-16, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d6612352220, moduleTitle=J Gastroenterol Hepatol：慢性乙型肝炎感染的自然史中，存在三种类型的起始密码子变异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d6612352220)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271261, encodeId=385a12e1261a7, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=Adv Clin Exp Med：乙肝病毒逆转录酶的突变积累与慢性乙型肝炎患者的肝病严重程度有关, objectType=article, longId=122827, objectId=9ea112282e87, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ea112282e87, replyNumber=0, likeNumber=75, createdTime=2017-12-10, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ea112282e87, moduleTitle=Adv Clin Exp Med：乙肝病毒逆转录酶的突变积累与慢性乙型肝炎患者的肝病严重程度有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ea112282e87)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271260, encodeId=566812e12604e, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=J Viral Hepat：定量胶原蛋白参数评估慢性乙型肝炎非进展期肝纤维化，诊断性能提高, objectType=article, longId=122820, objectId=a03f1228200d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a03f1228200d, replyNumber=0, likeNumber=59, createdTime=2017-12-10, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a03f1228200d, moduleTitle=J Viral Hepat：定量胶原蛋白参数评估慢性乙型肝炎非进展期肝纤维化，诊断性能提高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a03f1228200d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271259, encodeId=4b2b12e1259a4, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=SCI REP：循环miR-210和miR-22结合ALT预测慢性乙型肝炎患者进行IFN-α治疗的病毒学应答!, objectType=article, longId=120238, objectId=b0771202389f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0771202389f, replyNumber=0, likeNumber=73, createdTime=2017-11-17, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0771202389f, moduleTitle=SCI REP：循环miR-210和miR-22结合ALT预测慢性乙型肝炎患者进行IFN-α治疗的病毒学应答!, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b0771202389f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271258, encodeId=d47d12e125859, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=Gut：慢性乙型肝炎免疫耐受期患者肝细胞癌和死亡风险较高！, objectType=article, longId=119589, objectId=1e70119589cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e70119589cc, replyNumber=0, likeNumber=65, createdTime=2017-11-12, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e70119589cc, moduleTitle=Gut：慢性乙型肝炎免疫耐受期患者肝细胞癌和死亡风险较高！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e70119589cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271257, encodeId=2e1012e1257f1, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=聚乙二醇干扰素α治疗慢性乙型肝炎专家共识, objectType=article, longId=119062, objectId=6d19119062dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d19119062dd, replyNumber=0, likeNumber=27, createdTime=2017-11-08, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d19119062dd, moduleTitle=聚乙二醇干扰素α治疗慢性乙型肝炎专家共识, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d19119062dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271256, encodeId=7a3512e125614, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=Gut：免疫耐受期慢性乙型肝炎患者肝细胞癌和死亡的高危因素分析！, objectType=article, longId=117169, objectId=6ad711e169f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ad711e169f3, replyNumber=0, likeNumber=47, createdTime=2017-10-24, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ad711e169f3, moduleTitle=Gut：免疫耐受期慢性乙型肝炎患者肝细胞癌和死亡的高危因素分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ad711e169f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1271255, encodeId=ce5912e125582, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=Antivir Ther：慢性乙型肝炎患者血清细胞因子与趋化因子水平与抗病毒应答相关, objectType=article, longId=114761, objectId=0e41114e61d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e41114e61d6, replyNumber=0, likeNumber=70, createdTime=2017-09-30, rootId=0, userName=guguangxiang, userId=e11f100, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e41114e61d6, moduleTitle=Antivir Ther：慢性乙型肝炎患者血清细胞因子与趋化因子水平与抗病毒应答相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e41114e61d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

慢性乙型肝炎

2020-05-29

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

J Viral Hepat：抗病毒治疗后获得病毒抑制的慢性乙型肝炎患者与非活性期慢性乙型肝炎患者间整体存活率的比较

2018-05-12

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

《2018年亚裔美国人群慢性乙型肝炎管理专家共识》摘译

2018-05-11

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

Liver Int：在慢性乙型肝炎患者中，FibroStage是诊断显著纤维化、晚期纤维化和肝硬化的较好模型

2018-04-19

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

《2018年美国肝病学会乙型肝炎指导：慢性乙型肝炎预防、诊断和治疗（更新）》摘译

2018-04-13

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

Clin Transl Gastroenterol：慢性乙型肝炎患者并发症增加

2018-03-28

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

Hepatol Res：基线维生素D水平与慢性乙型肝炎患者遗传决定因素和病毒学应答的相关性

2018-03-20

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

2018 AASLD指南：慢性乙型肝炎的预防，诊断和治疗（更新版）

2018-03-14

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

Adv Clin Exp Med：乙型肝炎病毒逆转录酶的突变与慢性乙型肝炎患者的肝病严重程度相关

2018-02-12

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

Dig Liver Dis：一新型的非侵入性指标，用于预测慢性乙型肝炎患者中度至重度纤维化

2018-02-09

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

Liver Int：慢性乙型肝炎患者血清丙氨酸氨基转移酶水平及肝脏疾病相关死亡率的关系

2018-02-03

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

Gastroenterology：TLR7兴奋剂—GS-9620，增加了慢性乙型肝炎患者HBV特异性T细胞和自然杀伤细胞的反应

2018-02-02

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

二维剪切波弹性成像评估慢性乙型肝炎肝纤维化临床应用指南

2018-01-09

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

J Gastroenterol Hepatol：慢性乙型肝炎感染的自然史中，存在三种类型的起始密码子变异

2017-12-16

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

Adv Clin Exp Med：乙肝病毒逆转录酶的突变积累与慢性乙型肝炎患者的肝病严重程度有关

2017-12-10

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

J Viral Hepat：定量胶原蛋白参数评估慢性乙型肝炎非进展期肝纤维化，诊断性能提高

2017-12-10

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

SCI REP：循环miR-210和miR-22结合ALT预测慢性乙型肝炎患者进行IFN-α治疗的病毒学应答!

2017-11-17

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

Gut：慢性乙型肝炎免疫耐受期患者肝细胞癌和死亡风险较高！

2017-11-12

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

聚乙二醇干扰素α治疗慢性乙型肝炎专家共识

2017-11-08

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

Gut：免疫耐受期慢性乙型肝炎患者肝细胞癌和死亡的高危因素分析！

2017-10-24

guguangxiang (审核中...)

前往app查看评论内容

#慢性乙型肝炎#

Antivir Ther：慢性乙型肝炎患者血清细胞因子与趋化因子水平与抗病毒应答相关

2017-09-30

科室
- - 订阅+
  - 更多科室
工具
服务